Obsessive Compulsive Disorder



Computerized Training for Individuals Diagnosed With Obsessive-Compulsive Disorder


Condition:   Obsessive Compulsive Disorder
Intervention:   Behavioral: Computerized Training
Sponsor:   Stanford University
Not yet recruiting


Repetitive Transcranial Magnetic Stimulation (rTMS) for Obsessive-Compulsive Disorder (OCD)


Condition:   Obsessive-Compulsive Disorder
Intervention:   Device: Repetitive transcranial magnetic stimulation
Sponsor:   Sameer Sheth
Recruiting


Cognitive Training in Obsessive Compulsive Disorder


Condition:   Obsessive-Compulsive Disorder
Intervention:   Behavioral: n-Back (Cognitive Training)
Sponsors:   University of Stellenbosch;   University of Cape Town
Recruiting


Transcranial Direct Current Stimulation (tDCS) for Treatment-Resistant Obsessive-Compulsive Disorder (FRONT)


Condition:   Obsessive-Compulsive Disorder
Interventions:   Device: Active tDCS (transcranial direct current stimulation);   Device: Sham tDCS
Sponsors:   University of Sao Paulo;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting


Pharmacogenetic Study of Obsessive-Compulsive Disorder


Condition:   Obsessive-Compulsive Disorder
Intervention:   Drug: SSRIs
Sponsor:   Severance Hospital
Recruiting


Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)


Condition:   Obsessive-Compulsive Disorder
Intervention:   Drug: Ketamine
Sponsors:   New York State Psychiatric Institute;   New York Presbyterian Hospital
Recruiting


Attention Training for Childhood Obsessive Compulsive Disorder


Condition:   Obsessive Compulsive Disorder
Interventions:   Behavioral: Attention Modification Program;   Behavioral: Attention Control Condition
Sponsors:   University of California, Los Angeles;   National Institute of Mental Health (NIMH)
Completed


A Phase 3 Study of SME3110 in Pediatric/Adolescent Subjects With Obsessive Compulsive Disorder


Condition:   Obsessive Compulsive Disorder
Interventions:   Drug: fluvoxamine maleate;   Drug: placebo
Sponsors:   AbbVie;   Meiji Seika Pharma Co., Ltd.
Completed


Attention Training for Childhood Obsessive Compulsive Disorder: An Open Case Series


Condition:   Obsessive Compulsive Disorder
Intervention:   Behavioral: Attention Modification Program
Sponsors:   University of California, Los Angeles;   National Institute of Mental Health (NIMH)
Completed


Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder


Condition:   Obsessive-compulsive Disorder
Interventions:   Behavioral: Group-based family cognitive-behavioural therapy;   Other: Waitlist
Sponsors:   University of British Columbia;   Michael Smith Foundation for Health Research
Recruiting


Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder


Condition:   Obsessive Compulsive Disorder
Interventions:   Drug: Ketamine;   Drug: Midazolam
Sponsors:   Wayne Goodman MD;   Icahn School of Medicine at Mount Sinai
Terminated


Deep Brain Stimulation and Obsessive-compulsive Disorder


Condition:   Obsessive-Compulsive Disorder
Intervention:   Procedure: Deep Brain Stimulation (DBS)
Sponsor:   University Hospital, Bordeaux
Recruiting


N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder


Condition:   Obsessive-Compulsive Disorder
Interventions:   Drug: N-Acetylcysteine;   Drug: Placebo
Sponsor:   Yale University
Active, not recruiting


Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder


Condition:   Obsessive Compulsive Disorder
Interventions:   Drug: Agomelatine A;   Drug: Placebo
Sponsor:   Servier
Completed


A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder


Condition:   Obsessive-Compulsive Disorder
Interventions:   Drug: pregabalin;   Drug: Placebo
Sponsors:   Hamilton Health Sciences Corporation;   Pfizer
Recruiting


Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients


Condition:   Obsessive Compulsive Disorder
Interventions:   Drug: Quetiapine;   Drug: Clomipramine
Sponsors:   University of Sao Paulo;   Conselho Nacional de Desenvolvimento Científico e Tecnológico
Completed


Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment


Condition:   Obsessive Compulsive Disorder
Interventions:   Drug: Clomipramine (fluoxetine plus clomipramine);   Drug: Quetiapine (fluoxetine plus quetiapine);   Drug: Placebo (fluoxetine plus placebo)
Sponsors:   University of Sao Paulo;   Fundação de Amparo à Pesquisa do Estado de São Paulo;   Conselho Nacional de Desenvolvimento Científico e Tecnológico;   Novartis
Completed


Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)


Condition:   Obsessive Compulsive Disorder
Intervention:   Drug: Duloxetine
Sponsors:   Massachusetts General Hospital;   Eli Lilly and Company
Completed


Adjunctive Glycine for Obsessive Compulsive Disorder


Condition:   Obsessive Compulsive Disorder
Interventions:   Drug: glycine;   Other: placebo
Sponsors:   Nathan Kline Institute for Psychiatric Research;   Obsessive Compulsive Foundation
Completed


Memantine Augmentation in Obsessive-Compulsive Disorder


Condition:   Obsessive-Compulsive Disorder
Intervention:   Drug: Memantine
Sponsor:   Stanford University
Completed


Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder


Condition:   Obsessive Compulsive Disorder (OCD)
Intervention:   Drug: RG1068 (Synthetic Human Secretin)
Sponsors:   Indiana University School of Medicine;   Shekhar, Anantha M.D., Ph.D.;   Repligen Corporation
Completed


Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)


Condition:   Obsessive Compulsive Disorder
Interventions:   Drug: Topiramate;   Drug: placebo
Sponsors:   Hamilton Health Sciences Corporation;   Janssen-Ortho Inc., Canada
Recruiting


Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)


Condition:   Obsessive-Compulsive Disorder
Interventions:   Device: Repetitive Transcranial Magnetic Stimulation (rTMS);   Device: Sham
Sponsor:   New York State Psychiatric Institute
Completed


Characterization of Childhood-Onset Obsessive-Compulsive Disorder


Condition:   Obsessive-Compulsive Disorder
Intervention:  
Sponsor:   National Institute of Mental Health (NIMH)
Completed


Genetics of Obsessive-Compulsive Disorder


Condition:   Obsessive Compulsive Disorder
Intervention:  
Sponsor:   National Institute of Mental Health (NIMH)
Completed

Refine Your Search Advanced Search